Zeo ScientifiX ZEOX
OTC ZEOX
$0.79 -0.08 (-9.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Zeo ScientifiX (ZEOX) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Zeo ScientifiX (ZEOX) reported Return on Capital Employed [ROCE] of -3514.04% for fiscal Q2 2026 (quarter ended Apr 30, 2026).

Analysis

Zeo ScientifiX (ZEOX) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2023 (ended Oct 31, 2023), Zeo ScientifiX posted Return on Capital Employed [ROCE] of -1406.06%, up 239776.54 percentage points from FY2022.

  • By fiscal year, Return on Capital Employed [ROCE] came in at -241182.60% in FY2022.
  • The fiscal Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Zeo ScientifiX 6.78 Mn 3.36 Mn 2.06 Mn -3,514.04%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -3,514.04%
Apr 30, 2023 -1,846.86%
Jan 31, 2023 -511.47%
Oct 31, 2022 -2,797.63%
Oct 31, 2014 -1.06%
Apr 30, 2013 -189.42%
Jan 31, 2013 -3,581.65%
API Access

Zeo ScientifiX Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZEOX&period=max&api_key=YOUR_API_KEY